$25.13
0.090.36%
近くで: Nov 20, 4:00 PM EST
$25.18
0.050.2%
時間外: 7:35 PM EST

Veracyte (VCYT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $0.51 | $0.38 | 34.2 % |
| Q2 | Jul 30, 2026 | $0.54 | $0.41 | 31.7 % |
| Q1 | May 5, 2026 | $0.52 | $0.31 | 67.7 % |
| Q4 | Feb 25, 2026 | $0.53 | $0.36 | 47.2 % |
Quarterly Revenue (Billions)
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $151.75M | $147.18M | 3.11 % |
| Q2 | Jul 30, 2026 | $150.32M | $144.27M | 4.20 % |
| Q1 | May 5, 2026 | $139.07M | $130.40M | 6.65 % |
| Q4 | Feb 25, 2026 | $140.64M | $136.94M | 2.70 % |
Veracyte (VCYT) は、11 4, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$590M - $593Mの範囲と予想しています。
以前のガイダンスと比較して、Veracyteは売上高予測を以前の範囲である維持から$590M - $596Mに引き上げました。
Veracyteは、20から2 22, 2023の間に11 4, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 14 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.38 | $0.41 | $0.31 | $0.36 |
| Actual | $0.51 | $0.54 | $0.52 | $0.53 |
| Surprise | +34.2% | +31.7% | +67.7% | +47.2% |
| Revenue | ||||
| Estimate | $147.2M | $144.3M | $130.4M | $136.9M |
| Actual | $151.8M | $150.3M | $139.1M | $140.6M |
| Surprise | +3.11% | +4.20% | +6.65% | +2.70% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.35 | $0.30 | $0.29 | $0.32 |
| Revenue | ||||
| Consensus | $149.9M | $147.5M | — | — |